Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy

Brain

Volumn 135, Issue 9, 2012, Pages 2676-2683

  Musolino, Patricia Leonor ^a   Rapalino, Otto ^a   Caruso, Paul ^a   Caviness, Verne Strudwick ^a   Eichler, Florian Sebald ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

adrenoleukodystrophy; demyelination; leukodystrophy; MRI perfusion; neuroinflammation

Indexed keywords

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CEREBRAL X LINKED ADRENOLEUKODYSTROPHY; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FOLLOW UP; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 84866409542     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws206     Document Type: Article

References (22)

1. Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 1984; 91: 255-62.
2. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006; 27: 859-67.
3. Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, et al. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002; 58: 901-7.
4. Eichler FS, Ren JQ, Cossoy M, Rietsch AM, Nagpal S, Moser AB, et al. Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? Ann Neurol 2008; 63: 729-42.
5. Eichler F, Van Haren K. Immune response in leukodystrophies. Pediatr Neurol 2007; 37: 235-44.
6. Emblem KE, Bjornerud A. An automatic procedure for normalization of cerebral blood volume maps in dynamic susceptibility contrast-based glioma imaging. AJNR Am J Neuroradiol 2009; 30: 1929-32.
7. Ito R, Melhem ER, Mori S, Eichler FS, Raymond GV, Moser HW. Diffusion tensor brain MR imaging in X-linked cerebral adrenoleuko-dystrophy. Neurology 2001; 56: 544-7.
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
9. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004; 231: 645-52.
10. Lightman S, McDonald WI, Bird AC, Francis DA, Hoskins A, Batchelor JR, et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 1987; 110 (Pt 2): 405-14.
11. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman L, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994; 15: 1761-6.
12. Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003; 61: 369-74.
13. Melhem ER, Breiter SN, Ulug AM, Raymond GV, Moser HW. Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. AJR Am J Roentgenol 1996; 166: 689-95.
14. Melhem ER, Loes DJ, Georgiades CS, Raymond GV, Moser HW. X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. AJNR Am J Neuroradiol 2000; 21: 839-44.
15. Moser H, Smith K, Watkins P, Powers J, Moser A. X-linked adrenoleu-kodystrophy. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3257-301.
16. Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS, et al. X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 2000; 31: 227-39.
17. Putnam T. The pathogenesis of multiple sclerosis: a possible vascular factor. NEJM 1933; 209: 786-90.
18. Putnam T. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 1935; 32: 1298-321.
19. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 1975; 32: 577-91.
20. van der Voorn JP, Pouwels PJ, Powers JM, Kamphorst W, Martin JJ, Troost D, et al. Correlating quantitative MR imaging with histopathol-ogy in X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 2011; 32: 481-9.
21. van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystro-phy. Ann Neurol 2001; 49: 186-94.
22. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004; 127: 111-9.